HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sanguinarine combats hypoxia-induced activation of EphB4 and HIF-1α pathways in breast cancer.

AbstractBACKGROUND:
Breast cancer is the most common female cancer worldwide. Large hypoxic area is one of the features of tumor microenvironment. Highly activated hypoxia-induced pathways positively correlate with poor clinical response to chemo- and radiotherapy and high mortality in breast cancer patients.
PURPOSE:
We explore the effect of sanguinarine on hypoxia-induced activation of Ephrin type-B receptor 4 (EphB4) and hypoxia inducible factor-1α (HIF-1α) pathways in breast cancer.
RESULTS:
Hypoxia-induced expression of a receptor tyrosine kinase EphB4 was observed in hypoxic breast cancer cell models. Sanguinarine, a natural alkaloid, could effectively combat hypoxia-induced EphB4 and HIF-1α expression. Sanguinarine inhibited the activation of downstream protein signal transducer and activator of transcription-3 (STAT3), thereby blocking hypoxia-induced HIF-1α/STAT3 interaction and downregulating the mRNA levels of their target genes. Mechanically, sanguinarine attenuated HIF-1α protein levels via inhibition of MAPK/ERK pathways and promotion of HIF-1α proteasome degradation. Sanguinarine inhibited STAT3 activation through targeting its upstream EphB4 and accelerating STAT3 dephosphorylation. Correspondingly, xenograft models confirmed that sanguinarine treatment disrupted hypoxia-induced pathways and inhibited tumor growth in vivo.
CONCLUSIONS:
Our results may bring insights to the hypoxia-induced pathways in breast cancers, and suggest sanguinarine as a promising candidate for EphB4 and HIF-1α-targeted inhibition.
AuthorsQi Su, Jingjing Wang, Qing Wu, Asmat Ullah, Mohsin Ahmad Ghauri, Ammar Sarwar, Li Chen, Feng Liu, Yanmin Zhang
JournalPhytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 84 Pg. 153503 (Apr 2021) ISSN: 1618-095X [Electronic] Germany
PMID33636580 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Elsevier GmbH. All rights reserved.
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Benzophenanthridines
  • EPHB4 protein, human
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Isoquinolines
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • sanguinarine
  • Receptor, EphB4
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Benzophenanthridines (pharmacology)
  • Breast Neoplasms (drug therapy, metabolism, pathology)
  • Cell Line, Tumor
  • Female
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (genetics, metabolism)
  • Isoquinolines (pharmacology)
  • Mice, Inbred BALB C
  • Receptor, EphB4 (genetics, metabolism)
  • STAT3 Transcription Factor (metabolism)
  • Tumor Hypoxia (drug effects)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: